MMP7 and MMP3 are increasingly expressed in actively demyelinating MS lesions [212,213,214], implying their natural upregulation after a demyelinating insult, while MMP7 is absent in inactive MS lesions [211]. The gene discussed is MMP3; the disease is myeloid sarcoma.